Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “AIDS (Acquired Immune Deficiency Syndrome)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00002173
What this trial is testing

An Expanded Access Open Label Protocol of Remune (HIV-1 Immunogen) in HIV-1-Infected Adults With CD4 Count 550 Cells /Ml and Greater.

Who this might be right for
HIV Infections
The Immune Response Corporation
Not applicableStudy completedNCT03555669
What this trial is testing

Project SOAR-Mental Health Malawi: Depression and HIV Integration

Who this might be right for
DepressionHIV/AIDS
University of North Carolina, Chapel Hill 2,082
Not applicableStudy completedNCT04033718
What this trial is testing

Inpatient Package to Reduce HIV and AIDS-related Death in Zambia

Who this might be right for
HIV/AIDSTransitions of CareHospitalization+3 more
University of Alabama at Birmingham 72
Not applicableNot Yet RecruitingNCT07203261
What this trial is testing

Comparison of the Body Roundness Index and A Body Shape Index With Body Fat and Visceral Fat in People Living With HIV.

Who this might be right for
HIV/AIDS
Queens College, The City University of New York 65
Testing effectiveness (Phase 2)UnknownNCT00299897
What this trial is testing

SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients

Who this might be right for
HIV InfectionsHuman Immunodeficiency Virus
Samaritan Pharmaceuticals, Inc 60
Large-scale testing (Phase 3)Study completedNCT01939197
What this trial is testing

A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection

Who this might be right for
Hepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis C+1 more
AbbVie 318
Not applicableUnknownNCT05140603
What this trial is testing

Ambispective Cohort Study to Evaluate the Efficacy, Safety, and Tolerance of an Antiretroviral Regimen With Doravirine

Who this might be right for
Hiv
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 150
Testing effectiveness (Phase 2)Study completedNCT00002003
What this trial is testing

Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas

Who this might be right for
Lymphoma, Non-HodgkinHIV Infections
Lederle Laboratories
Early research (Phase 1)Study completedNCT00002373
What this trial is testing

The Safety and Effectiveness of Different Dose Levels of 1263W94 in the Treatment of Cytomegalovirus (CMV) of the Eyes in HIV-Infected Patients

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
Glaxo Wellcome 56
Large-scale testing (Phase 3)Study completedNCT02660905
What this trial is testing

HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection

Who this might be right for
Human Immunodeficiency VirusHepatitis C, Chronic
Ottawa Hospital Research Institute 25
Testing effectiveness (Phase 2)Study completedNCT00333684
What this trial is testing

Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-Alcamid

Who this might be right for
Human Immunodeficiency VirusFacial Lipoatrophy
Canadian Immunodeficiency Research Collaborative 36
Testing effectiveness (Phase 2)Study completedNCT00461552
What this trial is testing

Therapeutic Approaches to HAART-Induced Lipodystrophy

Who this might be right for
HIV InfectionsLipodystrophy
University of Texas Southwestern Medical Center 23
Not applicableStudy completedNCT05084716
What this trial is testing

Pre-Exposure Prophylaxis (PrEP) Provision for Ugandan Fisherfolk

Who this might be right for
HIV
RAND 885
Not applicableStudy completedNCT01020552
What this trial is testing

Integrating Family Planning Into Postabortion Care

Who this might be right for
Postabortion Care
FHI 360 300
Not applicableStudy completedNCT00002398
What this trial is testing

Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations

Who this might be right for
HIV Infections
Gilead Sciences
Not applicableStudy completedNCT03451032
What this trial is testing

Regional Multicenter Study to Evaluate Tolerability and Efficacy of TAF/FTC/RPV Combination (ODEFSEY ®) in Prevention of Sexual or Blood Exposure to HIV

Who this might be right for
Hiv
Nantes University Hospital 150
Not applicableStudy completedNCT03868644
What this trial is testing

The Impact of VCT and Condom Distribution as HIV Prevention Strategies Among Youth in Kenya

Who this might be right for
HIV/AIDSHSV-2 Infection
Abdul Latif Jameel Poverty Action Lab 10,646
Early research (Phase 1)Study completedNCT00058734
What this trial is testing

Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 5
Not applicableUnknownNCT05225493
What this trial is testing

HIV Indicator Diseases in Hospital and Primary Care

Who this might be right for
HIV InfectionsPrimary Health CareAcquired Immunodeficiency Syndrome+15 more
Erasmus Medical Center 1,500
Not applicableStudy completedNCT04025463
What this trial is testing

Healing Our Hearts Minds and Bodies: CVD Reduction in Persons With HIV

Who this might be right for
HIV/AIDSCardiovascular Risk FactorsTrauma, Psychological
University of California, Los Angeles 202
Next Page